Searched for
STRIDES PHARMA SHARE PRICE
Muthoot, Manappuram Finance shares jump up to 7% in 2 days as gold crosses Rs 1.6 lakh/10 gmGold loan stocks Muthoot Finance, Manappuram Finance and IIFL Finance gained up to 7% in two sessions as gold prices crossed Rs 1.6 lakh pe...- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Strides Pharma Science shares jump 9% after USFDA EIR for Bengaluru facilityStrides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru fa...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsHere’s one thing to watch for in the next few weeks: How does the street treat disappointments in the mid-cap segment? If the reaction is l...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities extended losses for a seventh session as rising oil prices and US-Iran tensions heightened risk aversion. Nifty fell to 24,...
- Two Trades for Today: A top EMS company for a 8.5% gain, a mid-cap IT stock for an almost 7% riseOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Sensex drops 326 points, Nifty closes below 23,100 as market bleeds for 7th session. What lies ahead?Indian equities extended their losing streak on Wednesday, with the Nifty 50 declining for a seventh consecutive session amid rising oil pr...
- Tiger Global-backed broking firm Upstox said to plan India IPOUpstox is currently in talks with investment banks regarding a possible initial public offering. Backed by Tiger Global, the company plans ...
- Delivering Gains! Shiprocket shares list at 35% premium over IPO priceShiprocket Share Price: The Rs 1,617.48-crore IPO, which was open for subscription from August 12 to August 14, received an overwhelming re...
- L&T Technology Services shares jump 3% after bagging $75 million dealL&T Technology Services shares gained up to 3.3% after the engineering services company secured a five-year deal worth more than $75 millio...
- Dividend alert! Last day to buy Mazagon Dock, Natco Pharma and 13 other stocks for dividends. Do you own any?Mazagon Dock Shipbuilders in April had announced that its board of directors have recommended a final dividend of Rs 4.62 per share for the...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities extended losses as fading Middle East peace hopes, elevated crude prices, rising US yields and weak global cues intensified...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
- Ahead of Market: 10 things that will decide stock market action on MondaySensex and Nifty ended last week lower amid range-bound trading, with broader markets also under pressure. Analysts identified four key fac...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- INDO-MIM, Ather Energy and TCS among stocks bought and sold by mutual funds in JulyMutual funds bought Rs 15,900 crore of stocks in July while FIIs sold Rs 11,000 crore. Axis Bank, INDO-MIM and Kotak Mahindra Bank saw majo...
- Marksans Pharma shares rally over 9% after Q1 profit spikes 174% YoY to Rs 159 croreMarksans Pharma shares surged after Q1FY27 profit jumped 174% YoY to Rs 159 crore. Revenue rose 35.6% to Rs 841 crore, while EBITDA hit a r...
- Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth promp...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
Load More
